Market Research Logo

Global Non-melanoma Skin Cancer Market 2018-2022

Global Non-melanoma Skin Cancer Market 2018-2022

About this market

Surgery is considered as the first line curative approach for NMSC, despite the presence of an extensive range of non-surgical treatment modalities. This is because surgery results in the highest cure rate. Surgical treatment provides superior outcomes regarding complete lesion response, clearance of NMSC, cumulative recurrence probabilities compared with cryotherapy, photodynamic therapy, radiotherapy, 5-FU, and imiquimod. Technavio’s analysts have predicted that the non-melanoma skin cancer market will register a CAGR of almost 6% by 2022.

Market Overview

Increase in incidence of NMSC

The white population in Europe, the US, and Australia are highly affected by NMSC, and the incidence of NMSC is increasing. Globally, NMSC differs significantly. Lower incidence rates are are registered in African countries and higher rates are observed in Australia. THE NMSC incidence rate is low in other parts of Europe compare to UK.

Few drugs in pipeline for NMSC

The drug pipeline for NMSC has very few molecules because of the low amount of R&D in this area. Non-disease modifying drugs are under evaluation. Most drugs are being evaluated for palliative care or as an adjuvant therapy. Various studies are being conducted to test newer targeted drugs for the treatment of advanced SCC.

For the detailed list of factors that will drive and challenge the growth of the non-melanoma skin cancer market during the 2018-2022, view our report.

Competitive Landscape

The market appears to be concentrated and with the presence of several companies including Bausch Health and F. Hoffmann-La Roche, the competitive environment is quite intense. Factors such as the increasing incidence of NMSC and NMSC coverage and support, will provide considerable growth opportunities to non-melanoma skin cancer manufactures. Bausch Health, F. Hoffmann-La Roche, Sun Pharmaceuticals, and 3M Pharmaceuticals are some of the major companies covered in this report.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Non-melanoma Skin Cancer Market 2018-2022

Technavio recognizes the following companies as the key players in the global non-melanoma skin cancer market: Bausch Health, F. Hoffmann-La Roche, Sun Pharmaceuticals, and 3M Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the high off-label use of topical treatments for NMSC.”

According to the report, one of the major drivers for this market is the rising incidence of NMSC across the globe, especially in Europe, the US, and Australia.

Further, the report states that one of the major factors hindering the growth of this market is the low data availability on NMSC statistics in cancer registries.

Companies Mentioned

Bausch Health
F. Hoffmann-La Roche
Sun Pharmaceuticals
3M Pharmaceuticals

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Global NMSC market
      • Table Global oncology market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • NMSC pipeline
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global - Market size and forecast 2017-2022 ($ mn)
      • Table Global - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by type of NMSC
    • Segmentation by type of NMSC
      • Table Type of NMSC - Market share 2017-2022 (%)
    • Comparison by type of NMSC
      • Table Comparison by type of NMSC
    • BCC - Market size and forecast 2017-2022
      • Table BCC - Market size and forecast 2017-2022 ($ mn)
      • Table BCC - Year-over-year growth 2018-2022 (%)
    • SCC - Market size and forecast 2017-2022
      • Table SCC - Market size and forecast 2017-2022 ($ mn)
      • Table SCC - Year-over-year growth 2018-2022 (%)
    • Market opportunity by type of NMSC
      • Table Market opportunity by type of NMSC
  • Market segmentation by therapy
    • Segmentation by therapy
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ mn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Increasing incidence of NMSC
    • Surgery considered as a first-line curative approach for NMSC
    • High off-label use of topical treatments for NMSC
    • Low physician adherence to NMSC diagnostic and treatment guidelines
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bausch Health
      • Table Bausch Health - Overview
      • Table Bausch Health - Business segments
      • Table Bausch Health - Organizational developments
      • Table Bausch Health - Geographic focus
      • Table Bausch Health - Segment focus
      • Table Bausch Health - Key offerings
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche - Overview
      • Table F. Hoffmann-La Roche - Business segments
      • Table F. Hoffmann-La Roche - Organizational developments
      • Table F. Hoffmann-La Roche - Geographic focus
      • Table F. Hoffmann-La Roche - Segment focus
      • Table F. Hoffmann-La Roche - Key offerings
    • Sun Pharmaceuticals
      • Table Sun Pharmaceuticals - Overview
      • Table Sun Pharmaceuticals - Business segments
      • Table Sun Pharmaceuticals - Organizational developments
      • Table Sun Pharmaceuticals - Geographic focus
      • Table Sun Pharmaceuticals - Segment focus
      • Table Sun Pharmaceuticals - Key offerings
    • 3M Pharmaceuticals
      • Table 3M Pharmaceuticals - Overview
      • Table 3M Pharmaceuticals - Business segments
      • Table 3M Pharmaceuticals - Organizational developments
      • Table 3M Pharmaceuticals - Geographic focus
      • Table 3M Pharmaceuticals - Segment focus
      • Table 3M Pharmaceuticals - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report